Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5170419, 7 pages
http://dx.doi.org/10.1155/2016/5170419
Research Article

Significance of “Not Detected but Amplified” Results by Real-Time PCR Method for HPV DNA Detection

1Department of Laboratory Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
2Department of Laboratory Medicine, Seoul National University Bundang Hospital, 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, Republic of Korea
3Department of Laboratory Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea

Received 24 March 2016; Accepted 21 November 2016

Academic Editor: Patrizia Cardelli

Copyright © 2016 Taek Soo Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Y. F. Ho, R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk, “Natural history of cervicovaginal papillomavirus infection in young women,” The New England Journal of Medicine, vol. 338, no. 7, pp. 423–428, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. N. F. Schlecht, S. Kulaga, J. Robitaille et al., “Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia,” Journal of the American Medical Association, vol. 286, no. 24, pp. 3106–3114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Koutsky, K. K. Holmes, C. W. Critchlow et al., “A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection,” The New England Journal of Medicine, vol. 327, no. 18, pp. 1272–1278, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Arbyn, X. Castellsagué, S. de sanjosé et al., “Worldwide burden of cervical cancer in 2008,” Annals of Oncology, vol. 22, no. 12, pp. 2675–2686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Zuo, S. Goel, and J. E. Carter, “Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth,” American Journal of Clinical Pathology, vol. 136, no. 2, pp. 260–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Evans, C. S.-C. Adamson, L. M. Schned et al., “HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests,” Diagnostic Molecular Pathology, vol. 19, no. 3, pp. 144–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. H. C. Kitchener, C. Gilham, A. Sargent et al., “A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial,” European Journal of Cancer, vol. 47, no. 6, pp. 864–871, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E.-M. De Villiers, C. Fauquet, T. R. Broker, H.-U. Bernard, and H. Zur Hausen, “Classification of papillomaviruses,” Virology, vol. 324, no. 1, pp. 17–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Muñoz, F. X. Bosch, S. de Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” The New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A.-B. Moscicki, L. Widdice, Y. Ma et al., “Comparison of natural histories of human papillomavirus detected by clinician-and self-sampling,” International Journal of Cancer, vol. 127, no. 8, pp. 1882–1892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. de Sanjosé, M. Diaz, X. Castellsagué et al., “Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis,” Lancet Infectious Diseases, vol. 7, no. 7, pp. 453–459, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Solomon, D. Davey, R. Kurman et al., “The 2001 bethesda system: terminology for reporting results of cervical cytology,” Journal of the American Medical Association, vol. 287, no. 16, pp. 2114–2119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Poljak, A. Oštrbenk, K. Seme et al., “Comparison of clinical and analytical performance of the Abbott RealTime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening,” Journal of Clinical Microbiology, vol. 49, no. 5, pp. 1721–1729, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-M. Kulmala, S. Syrjänen, I. Shabalova et al., “Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools,” Journal of Clinical Microbiology, vol. 42, no. 6, pp. 2470–2475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Monnier-Benoit, V. Dalstein, D. Riethmuller, N. Lalaoui, C. Mougin, and J. L. Prétet, “Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions,” Journal of Clinical Virology, vol. 35, no. 3, pp. 270–277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Schmitt, C. Depuydt, I. Benoy et al., “Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities,” Journal of Clinical Microbiology, vol. 51, no. 5, pp. 1458–1464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Huang, B. Erickson, N. Tang et al., “Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology,” Journal of Clinical Virology, vol. 45, supplement 1, pp. S19–S23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Molijn, B. Kleter, W. Quint, and L.-J. Van Doorn, “Molecular diagnosis of human papillomavirus (HPV) infections,” Journal of Clinical Virology, vol. 32, supplement 1, pp. S43–S51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. S. I. Collins, C. Constandinou-Williams, K. Wen et al., “Disruption of the E2 gene is a common and early event In the natural history of cervical human papillomavirus infection: a longitudinal cohort study,” Cancer Research, vol. 69, no. 9, pp. 3828–3832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Li, W. Wang, M. Si et al., “The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 12, pp. 1355–1361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Weaver, M. Shew, B. Qadadri et al., “Low-level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women,” Journal of Medical Virology, vol. 83, no. 8, pp. 1362–1369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Motamedi, G. Böhmer, H. H. Neumann, and R. von Wasielewski, “CIN III lesions and regression: retrospective analysis of 635 cases,” BMC Infectious Diseases, vol. 15, no. 1, article 541, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Evans, C. S.-C. Adamson, J. L. Papilio, T. L. S. John, G. Leiman, and K. Cooper, “Distribution of human papillomavirus types in ThinPrep papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes,” Cancer, vol. 106, no. 5, pp. 1054–1064, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Kinney, M. H. Stoler, and P. E. Castle, “Patient safety and the next generation of HPV DNA tests,” American Journal of Clinical Pathology, vol. 134, no. 2, pp. 193–199, 2010. View at Publisher · View at Google Scholar · View at Scopus